Pneumon 2020, 33(4):-0
Skipping a single dose of mepolizumab resulted in significant clinical and functional deterioration
Authors Information

2nd Respiratory Medicine Department, University of Athens Medical School,
Athens, Greece


Therapy with biologics is now the first choice of add on therapy in the management of severe asthma. However, little is known about the consequences of poor adherence to therapy on asthma control and lung function. Here, we report a case of an asthmatic patient with severe eosinophilic asthma whose asthma was ameliorated by mepolizumab use and whose symptoms had worsened, and asthma control was lost after skipping one single dose of the drug.

Pneumon 2020, 33(4):-0.